Literature DB >> 29491061

Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.

Marta Michalska1, Susanne Schultze-Seemann1, Irina Kuckuck1, Arndt Katzenwadel1, Philipp Wolf2.   

Abstract

BACKGROUND: Cisplatin-based chemotherapy is the treatment of choice for advanced bladder cancer. Since many tumor cells show inherent or acquired cisplatin resistance, research is needed to improve the therapeutic efficacy. Since the analgesic methadone is discussed as being a sensitizer for chemotherapy, we tested its effects on the cisplatin treatment of bladder cancer cells.
MATERIALS AND METHODS: T24 and HT-1376 bladder cancer cells were incubated with cisplatin in combination with methadone. Cytotoxicity was examined using the WST-1 viability assay and induction of apoptosis was analyzed via phase-contrast microscopy, flow cytometry, and western blot analysis.
RESULTS: Methadone was shown to enhance the cytotoxic effects of cisplatin on T24 cells based on the induction of apoptosis. In contrast, HT-1376 cells were identified as non-responders to methadone.
CONCLUSION: Methadone could act as a chemosensitizer in the future treatment of advanced bladder cancer. Further research is needed to identify the underlying molecular mechanisms. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Bladder cancer; chemosensitization; cisplatin; cytotoxicity; methadone

Mesh:

Substances:

Year:  2018        PMID: 29491061     DOI: 10.21873/anticanres.12360

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Against Repurposing Methadone for Glioblastoma Therapy.

Authors:  Tatjana Vatter; Lukas Klumpp; Katrin Ganser; Nicolai Stransky; Daniel Zips; Franziska Eckert; Stephan M Huber
Journal:  Biomolecules       Date:  2020-06-17

2.  Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent.

Authors:  Bodo Haas; Janine Ciftcioglu; Sanja Jermar; Sandra Weickhardt; Niels Eckstein; Bernd Kaina
Journal:  J Cancer Res Clin Oncol       Date:  2020-12-14       Impact factor: 4.553

3.  D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma.

Authors:  Cristian Urla; Irene Corteletti; Ann-Sophie Raible; Rupert Handgretinger; Jörg Fuchs; Steven W Warmann; Evi Schmid
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-19       Impact factor: 4.322

Review 4.  Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity.

Authors:  Azza El-Sheikh; Zenat Khired
Journal:  Medicina (Kaunas)       Date:  2021-12-28       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.